Having defined sclerostin regulation by the lysosome, we probed the clinical relevance using induced pluripotent stem cell (iPSC)-derived osteoblasts from Gaucher disease, a lysosomal storage disorder in which patients lack the lysosomal hydrolase glucocerebrosidase (GCase). The gene discussed is SOST; the disease is lysosomal storage disease.